| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74ecd433cbeeea53144edeb14aadcd0d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
1998-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_798778756d1c3c072e30a966342a6c40 |
| publicationDate |
1999-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9921583-A1 |
| titleOfInvention |
Method of inhibiting metastases of cancer cells |
| abstract |
The present invention relates to a method of inhibiting the metastases of cancer cells using a combination of radiation therapy and a matrix metalloproteinase-2 inhibitor, or a combination of a chemotherapeutic agent and a matrix metalloproteinase-2 inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0038717-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0038717-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9981918-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0038718-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0038718-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9428464-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6833373-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0037107-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0037107-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03075959-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10258621-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021084242-A1 |
| priorityDate |
1997-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |